News from kempharm, inc

Jun 03, 2014, 08:10 ET

KemPharm, Inc. Secures $60 Million Commitment from Deerfield

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Apr 30, 2014, 09:40 ET

KemPharm, Inc. Receives Notice of Allowance for Novel Prodrug of Hydromorphone

KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Mar 04, 2014, 08:33 ET

KemPharm, Inc. Expands Global Intellectual Property Estate for KP201

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Feb 26, 2014, 08:33 ET

KemPharm, Inc. to Present at Cowen and Company 34th Annual Health Care Conference

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Feb 05, 2014, 08:33 ET

KemPharm, Inc. to Present at 16th Annual BIO CEO & Investor Conference

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Jan 13, 2014, 09:39 ET

KemPharm Strengthens its Board of Directors as Company Prepares for Multiple Clinical and Business Milestones in 2014

KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Jan 09, 2014, 10:03 ET

KemPharm, Inc. to Present at Biotech Showcase™ 2014

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Dec 04, 2013, 14:53 ET

KemPharm, Inc. to Present at Oppenheimer 24th Annual Healthcare Conference in New York City

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Nov 01, 2013, 08:33 ET

KemPharm Completes Successful End-of-Phase 2 Meeting with FDA

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Oct 23, 2013, 08:10 ET

KemPharm Forms Physician Advisory Council Advocating "Intelligent Pain Therapeutic Development"

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Sep 25, 2013, 08:33 ET

KemPharm's KP201 Demonstrates Bioequivalence Compared to Norco® in Key Pivotal Clinical Study

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Sep 04, 2013, 08:33 ET

KemPharm Continues to Expand its Pain Therapy Pipeline with Discovery of KP606, a Novel Prodrug of Oxycodone

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Aug 28, 2013, 08:33 ET

KemPharm's KP201 to be Featured at PAINWeek 2013

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Aug 26, 2013, 08:33 ET

KemPharm's KP201 Demonstrates Complete Metabolic Cleavage of Prodrug and Steady-State Pharmacokinetic Profiles for Hydrocodone, Hydromorphone and Acetaminophen

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Aug 07, 2013, 08:10 ET

KemPharm, Inc. Receives Additional Notice of Allowance for Novel Prodrugs of Hydrocodone

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Jul 15, 2013, 08:10 ET

KemPharm, Inc. Appoints Gordon K. "Rusty" Johnson as Chief Operating Officer and Chief Financial Officer

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Jun 11, 2013, 08:33 ET

KemPharm, Inc. Receives Patent from the USPTO for Novel Pain Drug Candidate, KP201

KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Jun 04, 2013, 08:33 ET

KemPharm's KP201 Featured at the International Conference on Opioids

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Apr 16, 2013, 08:48 ET

KemPharm Advances KP201 Clinical and Commercial Program with Completion of Tablet Registration Activities

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Apr 03, 2013, 09:17 ET

KemPharm, Inc. Receives Notice of Allowance for Novel Pain Drug Candidate, KP201

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
ReportBuyer
Investor-Edge